Abbott Coronavirus Test Kit 
--Sharing is Caring--

Abbott Coronavirus Test Kit 

ABBOTT RELEASES MOLECULAR POINT-OF-CARE TEST TO DETECT NOVEL CORONAVIRUS IN AS LITTLE AS 5 MINUTES

  • The Abbott ID NOW ™ COVID-19 test brings rapid testing to the forefront
  • Test to work on Abbott’s point-of-care ID NOW platform – a portable instrument that can be installed where screening is required most
  • ID NOW has the biggest molecular point-of-care installed base in the U.S. and is available in a wide range of healthcare settings
  • Abbott will be making ID NOW COVID-19 tests available next week and expects to increase producing to provide 50,000 tests per day
  • This is Abbotts’s second test to get Emergency situation Usage Authorization by the FDA for COVID-19 detection; combined, Abbott anticipates to produce about 5 million tests monthly

Abbott revealed today that the U.S. Food and Drug Administration (FDA) has actually provided an Emergency Usage Permission (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), providing a favorable lead to as low as 5 minutes and negative results in 13 minutes. The test will work on the company’s ID NOW ™ platform, delivering fast results in a vast spectrum of health care settings such as doctors’ Clinics, urgent care clinics, and hospital emergency departments.

- Advertisement -
See Also
Smart Cells To Treat Diseases At Cellular Level By University Of Alberta

The ID NOW platform is a small, Ultra-light-weight (6.6 pounds) and Easily portable (the size of a small toaster Only), and uses molecular innovation, which is valued by clinicians and the scientific community for its highest possible degree of accuracy. ID NOW is infaxct already the most extensively used molecular point-of-care screening platform in the U.S.A today.

Testing being performed on Abbott’s ID NOW platform

“The COVID-19 pandemic will be fought on numerous fronts, and a portable molecular test that offers results in minutes contributes to the broad range of diagnostic options needed to combat this infection,” stated Robert B. Ford, president, and chief operating officer, Abbott. “With rapid testing on ID NOW, healthcare providers can perform molecular point-of-care testing outside the conventional four walls of a medical facility in outbreak hotspots.”

Abbott will be manufacturing ID NOW COVID-19 – Abbott Coronavirus Test Kit tests and will be offered next week to doctors in immediate & Urgent care settings in the U.S.A, where the majority of ID NOW instruments are in usage as of date. The company is cooperating with the USA national Administration to deploy tests to areas where they can have the greatest impact on the lives of citizens.

The Invention & arrival of the Abbott ID NOW COVID-19 test comes exactly a week after the company introduced its latest Test: Abbott m2000 ™ RealTime SARS-CoV-2 EUA test, which works on the m2000 ™ RealTime System situated in Hospital’s medical facility and referral laboratories all over the world. In between the 2 platforms, Abbott optimistically expects to produce around 5 million tests each month.

See Also
Scientists Discover Mechanism That Causes Nuclei To Grow

About the ID NOW ™ Molecular Platform

Abbott Coronavirus Test Kit

As a world leader in point-of-care diagnostics & Medical Services, Abbott is utilizing its expertise, knowledge, and scale to help combat the COVID-19 worldwide pandemic. Initially launched in the year 2014, ID NOW is the leading & Largest molecular point-of-care platform for Influenza A & B, Strep A and RSV testing in the U.S.A.

ID NOW is an Ultra-Fast, instrument-based, isothermal platform for the qualitative detection of transmittable diseases such as SARS COV-2. Its distinct isothermal nucleic acid amplification technology offers molecular results in a matter of simple minutes, enabling clinicians & Medical experts to make evidence-based medical choices during a patient go to.

About Abbott

Abbott is a global health care Industry leader that assists people to live fully at all stages of life. Our portfolio of life-changing innovations & Products spans the spectrum of healthcare, with leading organizations and items in diagnostics, medical gadgets, Nutritionals and top-quality generic medicines. Our 107,000 strong Staff serves individuals in more than 160 countries in the time of need.

Please note that the Abbott Coronavirus Test – ID NOW COVID-19 EUA has not been FDA cleared or approved. It has been licensed by the FDA under an emergency usage permission for usage by licensed labs and patient-care settings. The test has actually been approved only for the detection of nucleic acid from SARS-CoV-2, absolutely not for any other infections or pathogens, and is just licensed for the duration of the declaration that scenarios exist validating the authorization of emergency situation use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Area 564( b) (1) of the Act, 21 U.S.C. § 360bbb-3( b) (1 ), unless the permission is terminated or revoked quicker.

See Also
CSIR-IICT & Mylan Collaborates To Develop Potential COVID-19 Therapies  

SOURCE Abbott

Editors Note: Abbott Coronavirus Test Kit, 5 minutes coronavirus Test Kit by Abbott, COVID-19 Test kit

Shekhar Suman is the CEO & Managing Director of BioTecNika Info Labs Pvt Ltd, An avid reader who is passionate about Bio Sciences and has gifted us BioTecNika

1 COMMENT

Comments are closed.